Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SDZ HTF 919

Known as: HTF 919, SDZ HTF-919 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Actions of the 5-HT(4) serotonergic receptor partial agonist, tegaserod, were investigated on mucosal secretion in the guinea-pig… Expand
Is this relevant?
2004
2004
REASONS FOR PERFORMING STUDY It has been shown that the selective 5-HT4 receptor agonist tegaserod induces an increase in… Expand
Is this relevant?
2000
2000
BACKGROUND Tegaserod (HTF 919), a 5-HT4 receptor partial agonist, has prokinetic effects that might be useful in decreasing acid… Expand
Is this relevant?
1999
1999
Tegaserod (HTF 919) is a new drug being developed for gastrointestinal motility disorders. Because other gastrointestinal… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Previous studies have shown that the intestinal peristaltic reflex initiated by mucosal stimulation is mediated by release of 5… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
This study assessed the pharmacokinetic profiles of administering tegaserod (HTF 919) at different time intervals with respect to… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
BACKGROUND & AIMS The peristaltic reflex induced by mucosal stimuli is mediated by intrinsic sensory calcitonin gene-related… Expand
Is this relevant?
1997
1997
Effects of the nonbenzamide 5-hydroxytryptamine4 agonist SDZ HTF 919 on gastrointestinal motility are unclear. Our aim was to… Expand
Is this relevant?
1997
1997
OBJECTIVES To explore the pharmacodynamic effects of the new promotile agent SDZ HTF 919, a selective partial 5-HT4 receptor… Expand
Is this relevant?